Inhibition of antibody secretion by 5-aminosalicylic acid

Gastroenterology

Volumn 96, Issue 2 PART 1, 1989, Pages 442-448

  MacDermott, Richard P ^a   Schloemann, Suzanne R ^a   Bertovich, Michael J ^a   Nash, Geoffrey S ^a   Peters, Marion ^a   Stenson, William F ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE; SULFAPYRIDINE;

ANTIBODY PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINOSALICYLIC ACIDS; ANTIBODIES; CELL DIVISION; CELL SURVIVAL; HUMAN; IMMUNOGLOBULIN A; INDOMETHACIN; INTESTINAL MUCOSA; INTESTINES; MESALAMINE; MONOCYTES; POKEWEED MITOGENS; SULFAPYRIDINE; SULFASALAZINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024551739     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(89)91569-2     Document Type: Article

References (26)

1. Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis
2. Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon
3. Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study
4. Rectal mucosal plasma cells in inflammatory bowel disease
5. Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colons of patients with inflammatory bowel disease
6. Alterations of IgM, IgG, and IgA synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease
7. Synthesis and secretion of IgA, IgM, and IgG by peripheral blood mononuclear cells in human disease states, by isolated human intestinal mononuclear cells, and by human bone marrow mononuclear cells from ribs
8. Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease
9. Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls
10. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease
11. Inhibition of prostaglandin synthetase in human rectal mucosa
12. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils
13. Effect of sulfasalazine and its metabolites on the generation of reactive oxygen species
14. Separation of leucocytes from blood and bone marrow
15. Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities
16. Human intestinal mononuclear cells. II. Demonstration of a naturally occurring subclass of T cells which respond in the allogeneic mixed leukocyte reaction but do not effect cell-mediated lympholysis
17. Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease
18. A rapid miniaturized solid-phase radioimmunoassay technique for secreted immunoglobulins, employing microtiter plates, antibody bound to polyacrylamide beads, and filter strip harvesting
19. Alterations of the immune system in ulcerative colitis and Crohn's disease
20. Effects of sulfasalazine on selected lymphocyte subpopulations in vivo and in vitro
21. Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro
22. Increased suppressor cell activity in inflammatory bowel disease
23. Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients
24. Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes
25. Expression of human immunoglobulin G subclasses in inflammatory bowel disease
26. Prostaglandins